$ICU

SeaStar Medical Holding Corp

SeaStar Medical is a commercial-stage healthcare company developing and commercializing treatments for critically ill patients facing organ failure and other serious inflammatory diseases. Its Selective Cytopheretic Device (SCD) is an extracorporeal membrane device designed to modulate activated immune cells and is used with continuous renal replacement therapy systems. SeaStar Medical’s first commercial product, QUELIMMUNE, is an SCD therapy for critically ill pediatric patients with acute kidney injury due to sepsis or a septic condition. It has FDA approval under a Humanitarian Device Exemption and is sold to qualified healthcare facilities. The company also conducts clinical studies of SCD therapy in adults, including a pivotal trial for acute kidney injury and a feasibility study in cardiorenal syndrome. SeaStar Medical is headquartered in Denver, Colorado.

0
1
3
$9K
—
Chung Kevin
0%
See all $ICU insider activity →

Chung Kevin purchased $7K of ICU

Chung Kevin (Chief Medical Officer) purchased 7,800 shares of SeaStar Medical Holding Corp (ICU) at $0.84 on 2026-11-16.

SeaStar Medical Reports Third Quarter 2026 Financial Results and Provides Business Updates

SeaStar Medical Holding Corp (ICU) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 SeaStar Medical Reports Third Quarter 2026 Financial Results and Provides Business Updates Continued adoption of the QUELIMMUNE ® therapy yielded 247% increase in net revenue compared to the third quarter of 2025 Achieved nearly 75% enrollment in the NEUTRALIZE-AKI p

ICU sentiment & insider activity

Over the past 7 days, AlphAI's AI scored 4 news stories mentioning ICU (SeaStar Medical Holding Corp). Coverage has skewed bearish: 0 bullish, 1 neutral, and 3 bearish.

Recent ICU coverage spans earnings, financial news and insider activity.

In the last 30 days, ICU insiders filed 2 SEC Form 4 transactions — 2 purchases ($9K) and no sales. The most active reporter was Chung Kevin, Chief Medical Officer, with 1 filing.

What's driving ICU

AlphAI scores every news story that mentions ICU with an AI model for sentiment and relevance, and aggregates insider trades from SeaStar Medical Holding Corp's SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $ICU

Score
$ICUHighEarnings

SeaStar Medical Reports Third Quarter 2026 Financial Results and Provides Business Updates

SeaStar Medical Holding Corp (ICU) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 SeaStar Medical Reports Third Quarter 2026 Financial Results and Provides Business Updates Continued adoption of the QUELIMMUNE ® therapy yielded 247% increase in net revenue compared to the third quarter of 2025 Achieved nearly 75% enrollment in the NEUTRALIZE-AKI p

Related tickers